Acadia Healthcare Company, Inc. $ACHC Stake Raised by AXQ Capital LP

AXQ Capital LP raised its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 437.2% during the 4th quarter, HoldingsChannel reports. The fund owned 113,543 shares of the company’s stock after purchasing an additional 92,408 shares during the period. AXQ Capital LP’s holdings in Acadia Healthcare were worth $1,611,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Acadia Healthcare during the 1st quarter valued at about $1,600,000. Goldman Sachs Group Inc. lifted its holdings in shares of Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after purchasing an additional 27,207 shares during the last quarter. American Century Companies Inc. grew its position in Acadia Healthcare by 531.5% in the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after purchasing an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. lifted its position in Acadia Healthcare by 21.9% in the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after purchasing an additional 1,780 shares during the period.

Acadia Healthcare Trading Up 0.5%

NASDAQ ACHC opened at $23.31 on Tuesday. The firm has a market cap of $2.14 billion, a P/E ratio of -1.90, a P/E/G ratio of 7.80 and a beta of 0.73. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The stock’s 50-day moving average is $25.22 and its 200-day moving average is $19.47. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $30.20.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same quarter last year, the firm posted $0.40 earnings per share. Acadia Healthcare’s revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.49 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Leerink Partners raised their target price on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a research report on Thursday, February 26th. Royal Bank Of Canada upped their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Guggenheim upped their price target on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Barclays upped their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, April 30th. Finally, TD Cowen increased their target price on Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $26.42.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.